Published in Front Endocrinol (Lausanne) on March 02, 2017
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol (1994) 11.21
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25
Human chemokines: an update. Annu Rev Immunol (1997) 8.43
International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev (2000) 7.17
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (1990) 7.15
The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol (1994) 6.82
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation (2003) 5.20
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
Lymphocyte traffic control by chemokines. Nat Immunol (2001) 4.86
The cell and molecular biology of fracture healing. Clin Orthop Relat Res (1998) 4.65
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature (1999) 4.55
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol (1998) 4.51
Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A (1989) 3.88
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 3.74
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells (2007) 3.68
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med (1995) 2.99
Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med (1991) 2.96
Recent advances in chemokines and chemokine receptors. Crit Rev Immunol (1999) 2.78
Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71
Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum (2009) 2.64
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood (2005) 2.39
TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A (2011) 2.33
Structure-activity relationships of chemokines. J Leukoc Biol (1995) 2.15
Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem (2005) 2.10
Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol (2004) 2.09
Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem (1995) 2.08
Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol (1994) 1.99
Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells (2006) 1.84
Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem (2007) 1.79
Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol (1994) 1.77
International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev (2002) 1.77
Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest (1999) 1.57
Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci U S A (1993) 1.57
Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. J Orthop Res (2012) 1.56
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest (2007) 1.46
Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem (1997) 1.46
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol (2006) 1.44
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol (2004) 1.40
Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci U S A (1987) 1.33
The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun (2004) 1.30
The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci U S A (1999) 1.29
Multiple roles for CCR2 during fracture healing. Dis Model Mech (2010) 1.26
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood (2001) 1.25
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol (2000) 1.22
Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol (2003) 1.18
Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun (1990) 1.18
An evolving new paradigm: endothelial cells--conditional innate immune cells. J Hematol Oncol (2013) 1.17
Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol (2010) 1.17
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum (2001) 1.11
Role of endothelial chemokines and their receptors during inflammation. J Invest Surg (2011) 1.11
Identification, cloning, and characterization of an immune activation gene. Proc Natl Acad Sci U S A (1988) 1.07
Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood (1998) 1.05
Fracture healing perspectives. Clin Orthop Relat Res (1985) 1.05
Chemokine inhibition--why, when, where, which and how? Biochem Soc Trans (2004) 1.02
Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem (2011) 1.02
Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism. Cardiovasc Res (2006) 0.98
Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone (2008) 0.95
Monocyte chemotactic protein-3. Eur Cytokine Netw (2002) 0.94
Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis. Cancer Sci (2008) 0.92
Chemokine scavenging by D6: a movable feast? Trends Immunol (2006) 0.92
Fracture healing. Can J Surg (1975) 0.92
Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone (2012) 0.91
The aseptic femoral and tibial shaft non-union in healthy patients - an analysis of the health-related quality of life and the socioeconomic outcome. Open Orthop J (2011) 0.88
RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med (1998) 0.87
Chemokine receptor oligomerization: a further step toward chemokine function. Immunol Lett (2012) 0.87
The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization. J Biol Chem (2013) 0.87
Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination. Cell Adh Migr (2010) 0.86
MCP-1 expression is specifically regulated during activation of skeletal repair and remodeling. Calcif Tissue Int (2013) 0.85
Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo. J Orthop Res (2015) 0.84
The macrophage inflammatory proteins MIP1α (CCL3) and MIP2α (CXCL2) in implant-associated osteomyelitis: linking inflammation to bone degradation. Mediators Inflamm (2014) 0.84
Roles of CXCL5 on migration and invasion of liver cancer cells. J Transl Med (2014) 0.83
Duffy antigen receptor for chemokines regulates post-fracture inflammation. PLoS One (2013) 0.82
Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response. EMBO Mol Med (2015) 0.82
MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. PLoS One (2014) 0.81
Cytokine productive capacity of alveolar macrophages and Kupffer cells after femoral fracture and blunt chest trauma in a murine trauma model. Immunol Lett (2013) 0.80
CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity. Cancer Res (2016) 0.79
Significant advances have been made in the way surgeons treat fractures. Clin Orthop Relat Res (1998) 0.79
BMP2 Regulation of CXCL12 Cellular, Temporal, and Spatial Expression is Essential During Fracture Repair. J Bone Miner Res (2015) 0.79
Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation. Eur Cell Mater (2015) 0.78
CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface. Proc Natl Acad Sci U S A (2014) 0.78
TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose. Cytokine (2016) 0.77
Immunological characterization of the early human fracture hematoma. Immunol Res (2016) 0.77
HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation. Mol Med Rep (2016) 0.76
Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles. PLoS One (2016) 0.76
Co-culture of bone marrow stem cells and macrophages indicates intermediate mechanism between local inflammation and innate immune system in diabetic periodontitis. Exp Ther Med (2016) 0.76
Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur J Immunol (2016) 0.76
Exploiting agonist biased signaling of chemokines to target cancer. Mol Carcinog (2016) 0.76
Fracture healing and biomarker expression in a diabetic Zucker rat model. J Am Podiatr Med Assoc (2014) 0.76
CXCR4(+) CD45(-) Cells are Niche Forming for Osteoclastogenesis via the SDF-1, CXCL7, and CX3CL1 Signaling Pathways in Bone Marrow. Stem Cells (2016) 0.76
CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Med (2016) 0.75
Impaired healing of fragility fractures in type 2 diabetes: clinical and radiographic assessments and serum cytokine levels. Aging Clin Exp Res (2015) 0.75